Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Lachiewicz

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
CHEST Critical Care|November 29, 2024
Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data AnalysisAnne M Lachiewicz, Miloni Shah, Tatyana Der, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2024
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT)Vance G Fowler, Anita F Das, Joy Lipka-Diamond, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2020
Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans InfectionsNathaniel C Warner, Luther A Bartelt, Anne M Lachiewicz, et al.
Plos One|December 8, 2022
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical centerHeather B Root, Matt Gilleskie, Chih-Huan Lu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2022
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, et al.
JAMA|July 10, 2023
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialJane A O'Halloran, Emily R Ko, Kevin J Anstrom, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
CHEST Critical Care|November 29, 2024
Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data AnalysisAnne M Lachiewicz, Miloni Shah, Tatyana Der, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2024
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT)Vance G Fowler, Anita F Das, Joy Lipka-Diamond, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2020
Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans InfectionsNathaniel C Warner, Luther A Bartelt, Anne M Lachiewicz, et al.
Plos One|December 8, 2022
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical centerHeather B Root, Matt Gilleskie, Chih-Huan Lu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2022
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, et al.
JAMA|July 10, 2023
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialJane A O'Halloran, Emily R Ko, Kevin J Anstrom, et al.
Pageof 4